CVS
CVS Health Corporation
Stock
$85.20−0.49 (−0.57%)Close Oct 1, 2026
| EBITDA (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $12.8B | −5.7% | −12.8% | −2.2% |
| EBITDA (TTM) | $12.8B |
|---|---|
| YoY | −5.7% |
| 5-year CAGR | −12.8% |
| 10-year CAGR | −2.2% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $9.3B | −29.3% |
| 2024 | $13.1B | −27.6% |
| 2023 | $18.1B | +48.7% |
| 2022 | $12.2B | −31.6% |
| 2021 | $17.8B | −3.0% |
| 2020 | $18.4B | +12.2% |
| 2019 | $16.4B | +142.7% |
| 2018 | $6.7B | −43.9% |
| 2017 | $12.0B | −6.6% |
| 2016 | $12.9B | +11.2% |
| 2015 | $11.6B | +7.8% |
| 2014 | $10.7B | +8.3% |
| 2013 | $9.9B | +10.5% |
| 2012 | $9.0B | +13.5% |
| 2011 | $7.9B | +3.9% |
| 2010 | $7.6B | −2.7% |
| 2009 | $7.8B | +6.7% |
| 2008 | $7.3B | +24.3% |
| 2007 | $5.9B | — |